BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33267663)

  • 21. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
    Manne BK; Münzer P; Badolia R; Walker-Allgaier B; Campbell RA; Middleton E; Weyrich AS; Kunapuli SP; Borst O; Rondina MT
    J Thromb Haemost; 2018 Jun; 16(6):1211-1225. PubMed ID: 29575487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis.
    Wang X; Zhang S; Ding Y; Tong H; Xu X; Wei G; Chen Y; Ju W; Fu C; Qi K; Li Z; Zeng L; Xu K; Qiao J
    Redox Biol; 2020 Jul; 34():101569. PubMed ID: 32422541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel flow cytometry assay using dihydroethidium as redox-sensitive probe reveals NADPH oxidase-dependent generation of superoxide anion in human platelets exposed to amyloid peptide β.
    Abubaker AA; Vara D; Eggleston I; Canobbio I; Pula G
    Platelets; 2019; 30(2):181-189. PubMed ID: 29206074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice.
    Bynagari-Settipalli YS; Cornelissen I; Palmer D; Duong D; Concengco C; Ware J; Coughlin SR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2563-9. PubMed ID: 25278288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
    Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
    J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDF-15 prevents platelet integrin activation and thrombus formation.
    Rossaint J; Vestweber D; Zarbock A
    J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidine phosphorylase participates in platelet signaling and promotes thrombosis.
    Li W; Gigante A; Perez-Perez MJ; Yue H; Hirano M; McIntyre TM; Silverstein RL
    Circ Res; 2014 Dec; 115(12):997-1006. PubMed ID: 25287063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway.
    Begonja AJ; Gambaryan S; Geiger J; Aktas B; Pozgajova M; Nieswandt B; Walter U
    Blood; 2005 Oct; 106(8):2757-60. PubMed ID: 15976180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaempferol suppresses collagen-induced platelet activation by inhibiting NADPH oxidase and protecting SHP-2 from oxidative inactivation.
    Wang SB; Jang JY; Chae YH; Min JH; Baek JY; Kim M; Park Y; Hwang GS; Ryu JS; Chang TS
    Free Radic Biol Med; 2015 Jun; 83():41-53. PubMed ID: 25645952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
    Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
    Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
    Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis.
    Fuentes E; Gibbins JM; Holbrook LM; Palomo I
    Trends Cardiovasc Med; 2018 Oct; 28(7):429-434. PubMed ID: 29661712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.
    Musumeci L; Kuijpers MJ; Gilio K; Hego A; Théâtre E; Maurissen L; Vandereyken M; Diogo CV; Lecut C; Guilmain W; Bobkova EV; Eble JA; Dahl R; Drion P; Rascon J; Mostofi Y; Yuan H; Sergienko E; Chung TD; Thiry M; Senis Y; Moutschen M; Mustelin T; Lancellotti P; Heemskerk JW; Tautz L; Oury C; Rahmouni S
    Circulation; 2015 Feb; 131(7):656-68. PubMed ID: 25520375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation.
    Schinner E; Salb K; Schlossmann J
    Platelets; 2011; 22(3):217-27. PubMed ID: 21244222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
    Kaur H; Corscadden K; Ware J; Othman M
    Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUNDC2 regulates platelet activation through AKT/GSK-3β/cGMP axis.
    Ma Q; Zhang W; Zhu C; Liu J; Chen Q
    Cardiovasc Res; 2019 Sep; 115(11):1672-1679. PubMed ID: 30576423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
    Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
    Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.